Table 39 (Abstract P140). MEFV mutation analysis of SLE patients
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
|  | Mutation | n | Min | Max | Mean ± SD | Median | p |
|---|---|---|---|---|---|---|---|
Age of Diagnosis (Year) | No | 26 | 3 | 17 | 12,6 ± 3 | 13 | 0,79 |
Yes | 14 | 8 | 17 | 12,9 ± 2,8 | 13,5 | ||
Duration of disease (month) | No | 26 | 10 | 100 | 34,9 ± 19,8 | 31 | 0,69 |
Yes | 14 | 11 | 71 | 37,4 ± 16,8 | 42 | ||
SLICC | No | 26 | 0 | 3 | 0,4 ± 0,8 | 0 | 0,59 |
Yes | 14 | 0 | 2 | 0,5 ± 0,7 | 0 | ||
SLEDAI | No | 26 | 0 | 10 | 3,1 ± 3,2 | 2 | 0,62 |
Yes | 14 | 0 | 8 | 1,8 ± 2,5 | 1 |